Josh discusses the allure of investing in capital-efficient software companies, where rapid feedback and high market share potential exist, contrasted with the complexities and longer timelines of hard science investments. He highlights the trade-off between competing in crowded markets for a chance at massive returns versus investing in less competitive fields with a higher probability of success, albeit with potentially smaller outcomes.
